Parisi Gray Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.53M Sell
6,274
-183
-3% -$187K 1.54% 16
2026
Q1
$5.94M Buy
6,457
+5
+0.1% +$5.07K 1.41% 19
2025
Q4
$6.93M Buy
6,452
+10
+0.2% +$9.56K 1.57% 15
2025
Q3
$4.92M Buy
6,442
+49
+0.8% +$36.5K 1.28% 23
2025
Q2
$4.98M Buy
6,393
+33
+0.5% +$25.6K 1.43% 21
2025
Q1
$5.25M Buy
6,360
+689
+12% +$573K 1.72% 17
2024
Q4
$4.38M Buy
5,671
+65
+1% +$53.8K 1.39% 21
2024
Q3
$4.97M Buy
5,606
+38
+0.7% +$34.2K 1.64% 16
2024
Q2
$5.04M Buy
5,568
+70
+1% +$56K 1.81% 12
2024
Q1
$4.28M Buy
5,498
+75
+1% +$53.4K 1.6% 14
2023
Q4
$3.16M Buy
5,423
+2,010
+59% +$1.17M 1.28% 19
2023
Q3
$1.83M Buy
+3,413
New +$1.76M 0.83% 27
2021
Q3
Sell
-311
Closed -$71K 351
2021
Q2
$71K Buy
+311
New +$62.5K 0.03% 263
2019
Q2
Sell
-483
Closed -$63K 289
2019
Q1
$63K Hold
483
0.04% 187
2018
Q4
$55K Hold
483
0.04% 193
2018
Q3
$52K Hold
483
0.03% 219
2018
Q2
$42K Hold
483
0.03% 254
2018
Q1
$37K Hold
483
0.03% 258
2017
Q4
$41K Buy
+483
New +$41.1K 0.03% 243

Other funds holding LLY

Parisi Gray Wealth Management's LLY Position: Q2 2026 in Review

Parisi Gray Wealth Management reduced its Eli Lilly (LLY) stake by 2.8% in Q2 2026, selling an estimated $187K and leaving 6,274 shares worth $7.53M. The position accounts for 1.54% of the portfolio, ranked #16.

Parisi Gray Wealth Management first reported a position in LLY in Q4 2017 and has held it in 19 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Parisi Gray Wealth Management held 6,274 shares of Eli Lilly worth $7.53M as of Q2 2026.
  • Parisi Gray Wealth Management sold 183 Eli Lilly shares in Q2 2026, an estimated $187K.
  • Eli Lilly made up 1.54% of Parisi Gray Wealth Management's portfolio in Q2 2026, its #16 holding.
  • Parisi Gray Wealth Management first reported a position in Eli Lilly in Q4 2017 and has held it in 19 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Parisi Gray Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.